Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2020 2
2021 69
2022 155
2023 82
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

293 results

Results by year

Filters applied: . Clear all
Page 1
Covid-19 vaccines and variants of concern: A review.
Hadj Hassine I. Hadj Hassine I. Rev Med Virol. 2022 Jul;32(4):e2313. doi: 10.1002/rmv.2313. Epub 2021 Nov 9. Rev Med Virol. 2022. PMID: 34755408 Free PMC article. Review.
Currently, nine Covid-19 vaccine candidates based on the original Wuhan-Hu-1 strain are at the forefront of vaccine research. ...This review describes the most relevant mutations in the SARS-CoV-2 spike protein, discusses VE agains …
Currently, nine Covid-19 vaccine candidates based on the original Wuhan-Hu-1 strain are at the forefront of vaccine …
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review.
Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N. Fiolet T, et al. Clin Microbiol Infect. 2022 Feb;28(2):202-221. doi: 10.1016/j.cmi.2021.10.005. Epub 2021 Oct 27. Clin Microbiol Infect. 2022. PMID: 34715347 Free PMC article. Review.
BACKGROUND: Vaccines are critical cost-effective tools to control the coronavirus disease 2019 (COVID-19) pandemic. However, the emergence of variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may threaten the gl …
BACKGROUND: Vaccines are critical cost-effective tools to control the coronavirus disease 2019 (COVID-19) pandemic. How …
Tracking the COVID-19 vaccines: The global landscape.
Yadav T, Kumar S, Mishra G, Saxena SK. Yadav T, et al. Hum Vaccin Immunother. 2023 Dec 31;19(1):2191577. doi: 10.1080/21645515.2023.2191577. Epub 2023 Mar 30. Hum Vaccin Immunother. 2023. PMID: 36995773 Free PMC article. Review.
COVID-19: Coronavirus disease 2019; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; VLPs: Virus like particles; WHO: World Health Organization; E: Envelope; M: Membrane; S: Spike; N: Nucleocapsid; PRISMA: Preferred Reporting Items f …
COVID-19: Coronavirus disease 2019; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; VLPs: Vi …
COVID-19 Vaccines.
[No authors listed] [No authors listed] 2024 Feb 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2024 Feb 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 33355732 Free Books & Documents. Review.
Mothers who receive an mRNA vaccine have marked increases in milk antibodies that are similar to or higher than after a COVID-19 infection. ...No increase in serum anti-SARS-CoV-2 antibodies are found in infant serum after maternal vac …
Mothers who receive an mRNA vaccine have marked increases in milk antibodies that are similar to or higher than after a COVID- …
Safety and effectiveness of COVID-19 SPUTNIK V vaccine in dialysis patients.
Rosa-Diez G, Papaginovic Leiva MM, Lombi F, Crucelegui MS, Martínez RD, Trimarchi H, Schiavelli R, Grizzo M, Raño M, Heguilén RM, Jones RA, González Paganti L, Ferrrari M, Kjohede V, Zingoni P, Geffner JR, Ferrante D, González Bernaldo De Quirós F, Pagotto V. Rosa-Diez G, et al. Medicina (B Aires). 2022;82(5):631-640. Medicina (B Aires). 2022. PMID: 36220018 Free article. English.
The aims of this study were to evaluate the safety - measured by the adverse events potentially attributed to vaccines (ESAVI) - and the effectiveness - evaluated by the presence of antibodies - in dialysis patients immunized with the COVID-19 Sputnik …
The aims of this study were to evaluate the safety - measured by the adverse events potentially attributed to vaccines (ESAVI) - and …
Controversy surrounding the Sputnik V vaccine.
Cazzola M, Rogliani P, Mazzeo F, Matera MG. Cazzola M, et al. Respir Med. 2021 Oct;187:106569. doi: 10.1016/j.rmed.2021.106569. Epub 2021 Aug 10. Respir Med. 2021. PMID: 34399368 Free PMC article. Review.
The Sputnik V COVID-19 vaccine is a member of the so-called vector vaccines and uses two different vectors (Ad26 priming and Ad5 boost) to reduce the risk of a reduction in the effectiveness of the vaccination. Real life data indicate an …
The Sputnik V COVID-19 vaccine is a member of the so-called vector vaccines and uses two different vector …
COVID-19 vaccine demand protest might have increased vaccine acceptance and uptake in South Africa.
Mavundza EJ, Ndwandwe D, Wiysonge CS. Mavundza EJ, et al. Hum Vaccin Immunother. 2022 Nov 30;18(5):2064691. doi: 10.1080/21645515.2022.2064691. Epub 2022 Apr 18. Hum Vaccin Immunother. 2022. PMID: 35435798 Free PMC article.
Nevertheless, we believe that this march might have increased COVID-19 vaccine acceptance and uptake among EFF supporters. The endorsement of COVID-19 vaccines by Malema, an influential political figure in South Africa, probably convinced …
Nevertheless, we believe that this march might have increased COVID-19 vaccine acceptance and uptake among EFF supporte …
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination.
Röltgen K, Nielsen SCA, Silva O, Younes SF, Zaslavsky M, Costales C, Yang F, Wirz OF, Solis D, Hoh RA, Wang A, Arunachalam PS, Colburg D, Zhao S, Haraguchi E, Lee AS, Shah MM, Manohar M, Chang I, Gao F, Mallajosyula V, Li C, Liu J, Shoura MJ, Sindher SB, Parsons E, Dashdorj NJ, Dashdorj ND, Monroe R, Serrano GE, Beach TG, Chinthrajah RS, Charville GW, Wilbur JL, Wohlstadter JN, Davis MM, Pulendran B, Troxell ML, Sigal GB, Natkunam Y, Pinsky BA, Nadeau KC, Boyd SD. Röltgen K, et al. Cell. 2022 Mar 17;185(6):1025-1040.e14. doi: 10.1016/j.cell.2022.01.018. Epub 2022 Jan 25. Cell. 2022. PMID: 35148837 Free PMC article.
During the SARS-CoV-2 pandemic, novel and traditional vaccine strategies have been deployed globally. ...SARS-CoV-2 antibody specificity, breadth, and maturation are affected by imprinting from exposure history and distinct histolo …
During the SARS-CoV-2 pandemic, novel and traditional vaccine strategies have been deployed globally. ...SARS …
A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders.
Seirafianpour F, Pourriyahi H, Gholizadeh Mesgarha M, Pour Mohammad A, Shaka Z, Goodarzi A. Seirafianpour F, et al. Dermatol Ther. 2022 Jun;35(6):e15461. doi: 10.1111/dth.15461. Epub 2022 Apr 11. Dermatol Ther. 2022. PMID: 35316551 Free PMC article. Review.
With dermatologic side effects being fairly prevalent following vaccination against COVID-19, and the multitude of studies aiming to report and analyze these adverse events, the need for an extensive investigation on previous studies seemed urgent, in order t …
With dermatologic side effects being fairly prevalent following vaccination against COVID-19, and the multitude of stud …
New Onset Autoimmune Diseases after the Sputnik Vaccine.
Vera-Lastra O, Mora G, Lucas-Hernández A, Ordinola-Navarro A, Rodríguez-Chávez E, Peralta-Amaro AL, Medina G, Cruz-Dominguez MP, Jara LJ, Shoenfeld Y. Vera-Lastra O, et al. Biomedicines. 2023 Jul 4;11(7):1898. doi: 10.3390/biomedicines11071898. Biomedicines. 2023. PMID: 37509537 Free PMC article.
The vertiginous advance for identifying the genomic sequence of SARS-CoV-2 allowed the development of a vaccine including mRNA-based vaccines, inactivated viruses, protein subunits, and adenoviral vaccines such as Sputnik. This stu …
The vertiginous advance for identifying the genomic sequence of SARS-CoV-2 allowed the development of a vaccine …
[Assessment of the humoral immunity induced by Sputnik V COVID-19 vaccine (Gam-COVID-Vac) in healthcare workers].
Cordova E, Lespada MI, Cecchini D, Nieto F, Palonski S, Badran M, Bernasconi S, Bacelar B, Morganti L, Garibaldi F, Bermejo V, Aguirre V, Badia M, Rodriguez CG. Cordova E, et al. Vacunas. 2022 May;23:S14-S21. doi: 10.1016/j.vacun.2022.01.008. Epub 2022 Feb 14. Vacunas. 2022. PMID: 35185441 Free PMC article. Spanish.
Therefore, we aimed to evaluate the antibody response against SARS-CoV-2 in HCWs with complete Sputnik V vaccine scheme and factors associated with an increased antibody response. MATERIAL AND METHODS: Prospective study to evaluate the anti-S …
Therefore, we aimed to evaluate the antibody response against SARS-CoV-2 in HCWs with complete Sputnik V vacc …
Side effects and Immunogenicity following administration of the Sputnik V COVID-19 vaccine in health care workers in Iran.
Babamahmoodi F, Saeedi M, Alizadeh-Navaei R, Hedayatizadeh-Omran A, Mousavi SA, Ovaise G, Kordi S, Akbari Z, Azordeh M, Ahangarkani F, Alikhani A. Babamahmoodi F, et al. Sci Rep. 2021 Nov 2;11(1):21464. doi: 10.1038/s41598-021-00963-7. Sci Rep. 2021. PMID: 34728696 Free PMC article.
We provided independent evidence on side effects and immunogenicity following the administration of the Sputnik V COVID-19 in Iran. In this observational study, the healthcare workers who were vaccinated with the Sputnik V COVID-19 …
We provided independent evidence on side effects and immunogenicity following the administration of the Sputnik V COVID-19 …
A prospective cohort study protocol: monitoring and surveillance of adverse events following heterologous booster doses of Oxford AstraZeneca COVID-19 vaccine in previous recipients of two doses of Sinopharm or Sputnik V vaccines in Iran.
Soltani S, Matin BK, Gouya MM, Zahraei SM, Moradi G, Chehri O, Soofi M, Moradinazar M, Shadmani FK, Kalantari M, Khajeha H, Emamian MH, Najafi F. Soltani S, et al. BMC Public Health. 2023 Jul 24;23(1):1415. doi: 10.1186/s12889-023-16265-8. BMC Public Health. 2023. PMID: 37488541 Free PMC article.
BACKGROUND: Regarding the paucity of evidence on the side effects of the booster dose of Oxford AstraZeneca vaccine in vaccinated people with Sinopharm or Sputnik V, we aimed to set up a cohort event monitoring (CEM) study to capture adverse events occurring …
BACKGROUND: Regarding the paucity of evidence on the side effects of the booster dose of Oxford AstraZeneca vaccine in vaccinated …
ROCCA cohort study: Nationwide results on safety of Gam-COVID-Vac vaccine (Sputnik V) in the Republic of San Marino using active surveillance.
Di Valerio Z, La Fauci G, Soldà G, Montalti M, Lenzi J, Forcellini M, Barvas E, Guttmann S, Poluzzi E, Raschi E, Riccardi R, Fantini MP, Salussolia A, Gori D. Di Valerio Z, et al. EClinicalMedicine. 2022 Jul;49:101468. doi: 10.1016/j.eclinm.2022.101468. Epub 2022 May 20. EClinicalMedicine. 2022. PMID: 35614901 Free PMC article.
BACKGROUND: Gam-COVID-Vac is the world's first registered vector vaccine against COVID-19 based on a combination of two heterologous adenoviruses. ...INTERPRETATION: Our results confirm a good tolerability profile for the population aged 18 and over pr …
BACKGROUND: Gam-COVID-Vac is the world's first registered vector vaccine against COVID-19 based on a combination …
COVID-19 Vaccine-Related Arthritis: A Descriptive Study of Case Reports on a Rare Complication.
Dawoud R, Haddad D, Shah V, Patel V, Abbas G, Guduru S, Dakka A, Kaushik V, Cheriyath P. Dawoud R, et al. Cureus. 2022 Jul 9;14(7):e26702. doi: 10.7759/cureus.26702. eCollection 2022 Jul. Cureus. 2022. PMID: 35959192 Free PMC article. Review.
Large-scale coronavirus disease 2019 (COVID-19) vaccination programs have been rolled out worldwide. Vaccines that are widely used globally include mRNA vaccines, adenoviral vector vaccines, and inactivated whole-virus vaccines. …
Large-scale coronavirus disease 2019 (COVID-19) vaccination programs have been rolled out worldwide. Vaccines th …
Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates.
Tukhvatulin AI, Gordeychuk IV, Dolzhikova IV, Dzharullaeva AS, Krasina ME, Bayurova EO, Grousova DM, Kovyrshina AV, Kondrashova AS, Avdoshina DV, Gulyaev SA, Gulyaeva TV, Moroz AV, Illarionova VV, Zorkov ID, Iliukhina AA, Shelkov AY, Botikov AG, Erokhova AS, Shcheblyakov DV, Esmagambetov IB, Zubkova OV, Tokarskaya EA, Savina DM, Vereveyko YR, Ungur AS, Naroditsky BS, Ishmukhametov AA, Logunov DY, Gintsburg AL. Tukhvatulin AI, et al. Emerg Microbes Infect. 2022 Dec;11(1):2229-2247. doi: 10.1080/22221751.2022.2119169. Emerg Microbes Infect. 2022. PMID: 36031930 Free PMC article.
Vaccines are considered the most effective way to prevent infectious diseases, which has been reaffirmed for COVID-19. ...We also demonstrate that Sputnik V vaccine can provide sterilizing immunity in K18-hACE2 transgenic mice exposed to experim …
Vaccines are considered the most effective way to prevent infectious diseases, which has been reaffirmed for COVID-19. …
ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance.
Montalti M, Soldà G, Di Valerio Z, Salussolia A, Lenzi J, Forcellini M, Barvas E, Guttmann S, Messina R, Poluzzi E, Raschi E, Riccardi R, Fantini MP, La Fauci G, Gori D; San Marino Republic COVID ROCCA Group. Montalti M, et al. EClinicalMedicine. 2021 Jul 8;38:101027. doi: 10.1016/j.eclinm.2021.101027. eCollection 2021 Aug. EClinicalMedicine. 2021. PMID: 34505029 Free PMC article.
BACKGROUND: In August 2020, Sputnik V was registered as Gam-COVID-Vac by the Russian Ministry of Health, and since December 2020 it has been distributed in 61 countries worldwide. On 25 February 2021, the Republic of San Marino started its vaccination campaig …
BACKGROUND: In August 2020, Sputnik V was registered as Gam-COVID-Vac by the Russian Ministry of Health, and since December 20 …
Covid-19 Vaccine safety and adverse event analysis from Pakistan.
Hasan SS, Rashid A, Osama S, Mustafa ZU, Merchant HA. Hasan SS, et al. Clin Immunol Commun. 2022 Dec;2:91-97. doi: 10.1016/j.clicom.2022.05.003. Epub 2022 May 14. Clin Immunol Commun. 2022. PMID: 38013971 Free PMC article.
The Covid vaccine AEFIs in Pakistan were mainly reported via NIMS (National Immunization Management System), COVIM (Covid-19 Vaccine Inventory Management System), 1166 freephone helpline and MedSafety. ...Finally, Covid vaccines we …
The Covid vaccine AEFIs in Pakistan were mainly reported via NIMS (National Immunization Management System), COVIM (Covid …
Severe Persistent Eczema in a Recipient of the Gam-COVID-Vac vaccine.
Ameri M, Abolmaali M, Alwedaie SMJ, Nabavi M, Rahimian N, Hamidabad NM. Ameri M, et al. Eur J Case Rep Intern Med. 2022 Jan 12;9(1):003042. doi: 10.12890/2022_003042. eCollection 2022. Eur J Case Rep Intern Med. 2022. PMID: 35169571 Free PMC article.
Since the beginning of the COVID-19 pandemic, efforts have been made to design safe and effective vaccines against SARS-CoV-2. ...LEARNING POINTS: Vaccination against COVID-19 may be accompanied by rare complications. …
Since the beginning of the COVID-19 pandemic, efforts have been made to design safe and effective vaccines against S …
Sputnik V vaccine perception and hesitancy in a tertiary health care centre transformed to Covid-19 vaccine centre: A case study.
Priyadharshini A, Begum J, Ali SI, Pattnaik S, Sharma D, Lalitha DL. Priyadharshini A, et al. J Educ Health Promot. 2023 Oct 31;12:366. doi: 10.4103/jehp.jehp_322_23. eCollection 2023. J Educ Health Promot. 2023. PMID: 38144010 Free PMC article.
BACKGROUND: Sputnik V vaccine was approved in India in April 2021 to tackle the pandemic situation. ...The mean age of the participant was 29 + 9.5 years and majority 68.5% were males. Seventeen percent experienced the S/E for the vaccine with 9.5% from secon …
BACKGROUND: Sputnik V vaccine was approved in India in April 2021 to tackle the pandemic situation. ...The mean age of the par …
Vaccine-associated complications: a comparative multicenter evaluation among dental practitioners and dental students-which candidate vaccine is more safe in SARS COV II, Gam-COVID-Vac (Sputnik V), ChAdOx1 nCoV-19 (AstraZeneca), BBV152 (Covaxin), or BBIBP-CorV(Sinopharm)?
Houshmand B, Keyhan SO, Fallahi HR, Ramezanzade S, Sadeghi E, Yousefi P. Houshmand B, et al. Maxillofac Plast Reconstr Surg. 2022 Jan 13;44(1):3. doi: 10.1186/s40902-021-00330-6. Maxillofac Plast Reconstr Surg. 2022. PMID: 35025010 Free PMC article.
This study aimed to evaluate current vaccination non-serious/serious side effects. METHODS: A multicenter electronic questionnaire via an online platform was conducted over a 1-week period among vaccinated dental staff and dental students inquiring whether they expe …
This study aimed to evaluate current vaccination non-serious/serious side effects. METHODS: A multicenter electronic questionnaire vi …
A Review on Immunological Responses to SARS-CoV-2 and Various COVID-19 Vaccine Regimens.
Upreti S, Samant M. Upreti S, et al. Pharm Res. 2022 Sep;39(9):2119-2134. doi: 10.1007/s11095-022-03323-w. Epub 2022 Jul 1. Pharm Res. 2022. PMID: 35773445 Free PMC article. Review.
The transmission of SARS-CoV-2 has caused serious health crises globally. So far, 7 vaccines that are already being assessed in Phase IV clinical trials are, Comirnaty/ Pfizer; Spikevax/Moderna (m RNA vaccine); Vaxzevria or Covishield; Ad26.COV2 …
The transmission of SARS-CoV-2 has caused serious health crises globally. So far, 7 vaccines that are already be …
Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance.
Shkoda AS, Gushchin VA, Ogarkova DA, Stavitskaya SV, Orlova OE, Kuznetsova NA, Keruntu EN, Pochtovyi AA, Pukhov AV, Kleymenov DA, Krzhanovsky VG, Vasina DV, Shkuratova NV, Shidlovskaya EV, Gorbunov AL, Kustova DD, Mazurina EA, Kozlova SR, Soboleva AV, Grigoriev IV, Pankratyeva LL, Odintsova AS, Belyaeva ED, Bessonova AA, Vasilchenko LA, Lupu IP, Adgamov RR, Tkachuk AP, Tokarskaya EA, Logunov DY, Gintsburg AL. Shkoda AS, et al. Vaccines (Basel). 2022 Jun 13;10(6):938. doi: 10.3390/vaccines10060938. Vaccines (Basel). 2022. PMID: 35746546 Free PMC article.
Mass vaccination campaigns against COVID-19 affected more than 90% of the population in most developed countries. ...Thus, present study indicates the high protective efficacy of vaccination against hospitalization with COVID-19 in case o …
Mass vaccination campaigns against COVID-19 affected more than 90% of the population in most developed countries. ...Th …
Fractionating a COVID-19 Ad5-vectored vaccine improves virus-specific immunity.
Sanchez S, Palacio N, Dangi T, Ciucci T, Penaloza-MacMaster P. Sanchez S, et al. Sci Immunol. 2021 Dec 3;6(66):eabi8635. doi: 10.1126/sciimmunol.abi8635. Epub 2021 Dec 3. Sci Immunol. 2021. PMID: 34648369 Free PMC article.
SARS-CoV-2 has caused a global pandemic that has infected more than 250 million people worldwide. ...We performed mechanistic studies in mice to understand how the priming dose of an adenovirus-based SARS-CoV-2 vaccine affects long …
SARS-CoV-2 has caused a global pandemic that has infected more than 250 million people worldwide. ...We performed mecha …
Plausibility of Claimed Covid-19 Vaccine Efficacies by Age: A Simulation Study.
Sheldrick KA, Meyerowitz-Katz G, Tucker-Kellogg G. Sheldrick KA, et al. Am J Ther. 2022 Sep-Oct 01;29(5):e495-e499. doi: 10.1097/MJT.0000000000001528. Epub 2022 Jun 20. Am J Ther. 2022. PMID: 35723559
BACKGROUND: Multiple vaccines against Covid-19 have passed through phase-3 trials; however, concerns have been raised about alleged excessive similarity of efficacy across age groups for the Sputnik V vaccine. ...CONCLUSIONS: The distribution of …
BACKGROUND: Multiple vaccines against Covid-19 have passed through phase-3 trials; however, concerns have been raised a …
COVID-19-Impfungen: Replizierend oder Nichtreplizierend?
Klimek L, Chaker AM, Cuevas M, Becker S. Klimek L, et al. Laryngorhinootologie. 2021 Aug;100(8):603-607. doi: 10.1055/a-1509-8916. Epub 2021 May 27. Laryngorhinootologie. 2021. PMID: 34044465 German.
The Gamaleya institute developed the COVID-19 vaccine named Sputnik (Gam-COVID-Vac) using adenoviral vectors ad 26 and ad5 to incorporate a full SARS-Spike Protein for vaccination. ...Patient subgroups and vaccination efficacy in h …
The Gamaleya institute developed the COVID-19 vaccine named Sputnik (Gam-COVID-Vac) using adenoviral vect …
Sputnik V protection from COVID-19 in people living with HIV under antiretroviral therapy.
Gushchin VA, Tsyganova EV, Ogarkova DA, Adgamov RR, Shcheblyakov DV, Glukhoedova NV, Zhilenkova AS, Kolotii AG, Zaitsev RD, Logunov DY, Gintsburg AL, Mazus AI. Gushchin VA, et al. EClinicalMedicine. 2022 Mar 24;46:101360. doi: 10.1016/j.eclinm.2022.101360. eCollection 2022 Apr. EClinicalMedicine. 2022. PMID: 35340627 Free PMC article.
BACKGROUND: HIV-infection is known to aggravate the course of many infectious diseases, including COVID-19. International guidance recommends vaccination of HIV+ individuals against SARS-CoV-2. There is a paucity of data on epidemiologica …
BACKGROUND: HIV-infection is known to aggravate the course of many infectious diseases, including COVID-19. International guid …
Effects of COVID-19 on the Course of Epilepsy.
Odintsova GV, Nezdorovin OV, Nezdorovina VG. Odintsova GV, et al. Neurosci Behav Physiol. 2022;52(7):963-967. doi: 10.1007/s11055-022-01323-2. Epub 2022 Dec 23. Neurosci Behav Physiol. 2022. PMID: 36575725 Free PMC article.
A comparative analysis of two case histories showing the effects of COVID-19 and immunization with the Sputnik V vaccine on the dynamics of epilepsy is presented. The study was part of the "Epilepsy and COVID-19" research initiative in a …
A comparative analysis of two case histories showing the effects of COVID-19 and immunization with the Sputnik V vac …
Sputnik V vaccine-related complications and its impression on inflammatory biomarkers in healthcare providers.
Akrami M, Hosamirudsari H, Faraji N, Behnush B, Goudarzi F, Hesari E, Akbarpour S, Najafi A, Nateghi S. Akrami M, et al. Indian J Med Microbiol. 2023 May-Jun;43:79-84. doi: 10.1016/j.ijmmb.2022.10.012. Epub 2022 Nov 7. Indian J Med Microbiol. 2023. PMID: 36357266 Free PMC article.
PURPOSE: The current pandemic made scientists create new platforms of vaccines to fight against SARS-CoV-2. Without a doubt, the new forms of present vaccines could develop a diversity of unknown complications. ...However, there are controversie …
PURPOSE: The current pandemic made scientists create new platforms of vaccines to fight against SARS-CoV-2. With …
Sputnik V vaccine goes global.
Lawton G. Lawton G. New Sci. 2021 Apr 24;250(3331):10-11. doi: 10.1016/S0262-4079(21)00671-0. Epub 2021 Apr 23. New Sci. 2021. PMID: 33935343 Free PMC article.
Non-Western vaccines are serious players in the global effort against covid-19, but we need more transparent data, reports Graham Lawton....
Non-Western vaccines are serious players in the global effort against covid-19, but we need more transparent data, repo …
COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms: a review.
Simnani FZ, Singh D, Kaur R. Simnani FZ, et al. 3 Biotech. 2022 Jan;12(1):15. doi: 10.1007/s13205-021-03076-0. Epub 2021 Dec 12. 3 Biotech. 2022. PMID: 34926119 Free PMC article. Review.
However, the SARS-CoV-2 is constantly mutating, making the vaccines less effective, possibly by escaping immune response for some variants. ...Although the COVID-19 vaccine candidates promise to overcome the pandemic, a more signif …
However, the SARS-CoV-2 is constantly mutating, making the vaccines less effective, possibly by escaping immune …
Covid-19 Vaccines Available in India.
Mukim M, Sharma P, Patweker M, Patweker F, Kukkar R, Patel R. Mukim M, et al. Comb Chem High Throughput Screen. 2022;25(14):2391-2397. doi: 10.2174/1386207325666220315115953. Comb Chem High Throughput Screen. 2022. PMID: 35293291 Review.
The present review covers the list of approved vaccines available in India, i.e., Covaxin, Covishield, and Sputnik-V. ...Covaxin releases Anti-SARS-CoV-2 IgG, which is specific to RBD (receptor-binding domain) protein, whereas a high degree of a …
The present review covers the list of approved vaccines available in India, i.e., Covaxin, Covishield, and Sputnik-V. ...Covax …
An assessment of the strategy and status of COVID-19 vaccination in India.
Gupta SL, Goswami S, Anand A, Naman N, Kumari P, Sharma P, Jaiswal RK. Gupta SL, et al. Immunol Res. 2023 Aug;71(4):565-577. doi: 10.1007/s12026-023-09373-5. Epub 2023 Apr 11. Immunol Res. 2023. PMID: 37041424 Free PMC article. Review.
India is one of the leading countries to set clinical trials, production, and administration of COVID-19 vaccination. Recent COVID-19 vaccine tracker record suggests that 12 vaccines are approved in India, including protein subunit …
India is one of the leading countries to set clinical trials, production, and administration of COVID-19 vaccination. R …
Anti-S and Anti-N Antibody Responses of COVID-19 Vaccine Recipients.
Al-Shudifat AE, Al-Tamimi M, Dawoud R, Alkhateeb M, Mryyian A, Alahmad A, Abbas MM, Qaqish A. Al-Shudifat AE, et al. Vaccines (Basel). 2023 Aug 22;11(9):1398. doi: 10.3390/vaccines11091398. Vaccines (Basel). 2023. PMID: 37766076 Free PMC article.
The long-term immunoglobulin responses of COVID-19 vaccinations is important to determine the efficacy of these vaccinations. ...Individuals who were infected with COVID-19 after receiving the vaccine demonstrated higher levels of …
The long-term immunoglobulin responses of COVID-19 vaccinations is important to determine the efficacy of these vacc …
A Hitchhiker's Guide to Worldwide COVID-19 Vaccinations: A Detailed Review of Monovalent and Bivalent Vaccine Schedules, COVID-19 Vaccine Side Effects, and Effectiveness Against Omicron and Delta Variants.
Goyal L, Zapata M, Ajmera K, Chaurasia P, Pandit R, Pandit T. Goyal L, et al. Cureus. 2022 Oct 2;14(10):e29837. doi: 10.7759/cureus.29837. eCollection 2022 Oct. Cureus. 2022. PMID: 36204257 Free PMC article. Review.
For the primary prevention of coronavirus disease 2019 (COVID-19), there are currently four different vaccines available in the USA. ...This article also briefly covers COVID-19 vaccines available worldwide, specifically their mode of act …
For the primary prevention of coronavirus disease 2019 (COVID-19), there are currently four different vaccines availabl …
Prevalence of COVID-19 vaccines (Sputnik V, AZD-1222, and Covaxin) side effects among healthcare workers in Birjand city, Iran.
Zare H, Rezapour H, Mahmoodzadeh S, Fereidouni M. Zare H, et al. Int Immunopharmacol. 2021 Dec;101(Pt B):108351. doi: 10.1016/j.intimp.2021.108351. Epub 2021 Nov 10. Int Immunopharmacol. 2021. PMID: 34801416 Free PMC article.
This study was designed to investigate the side effects of the first dose of COVID-19 vaccine; Sputnik-V, AZD-1222, and Covaxin. METHODS: A study was performed to evaluate the side effects of these vaccine among 503 health care workers in Birjan …
This study was designed to investigate the side effects of the first dose of COVID-19 vaccine; Sputnik-V, AZD-12 …
Estimating the cost of COVID-19 vaccine deployment and introduction in Ghana using the CVIC tool.
Nonvignon J, Owusu R, Asare B, Adjagba A, Aun YW, Yeung KHT, Azeez JNK, Gyansa-Lutterodt M, Gulbi G, Amponsa-Achiano K, Dadzie F, Armah GE, Brenzel L, Hutubessy R, Resch SC; Ghana Health Technology Assessment Technical Working Group. Nonvignon J, et al. Vaccine. 2022 Mar 15;40(12):1879-1887. doi: 10.1016/j.vaccine.2022.01.036. Epub 2022 Feb 4. Vaccine. 2022. PMID: 35190206 Free PMC article.
BACKGROUND: This study estimated cost of COVID-19 vaccine introduction and deployment in Ghana. METHODS: Using the WHO-UNICEF COVID-19 Vaccine Introduction and deployment Costing (CVIC) tool Ghana's Ministry of Health Technical Working Gr …
BACKGROUND: This study estimated cost of COVID-19 vaccine introduction and deployment in Ghana. METHODS: Using the WHO- …
Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination: Author's response.
Pereson MJ, Neukam K, Amaya L, Bare P, Echegoyen N, Badano MN, Lucero A, Martelli A, Garcia GH, Videla C, Martínez AP, Di Lello FA. Pereson MJ, et al. Clin Microbiol Infect. 2022 Nov;28(11):1514-1515. doi: 10.1016/j.cmi.2022.06.007. Epub 2022 Jun 17. Clin Microbiol Infect. 2022. PMID: 35724868 Free PMC article. No abstract available.
Bell's palsy after Sputnik V COVID-19 (Gam-COVID-Vac) vaccination.
Mirmosayyeb O, Barzegar M, Rezaei M, Baharlouie N, Shaygannejad V. Mirmosayyeb O, et al. Clin Case Rep. 2022 Feb 23;10(2):e05468. doi: 10.1002/ccr3.5468. eCollection 2022 Feb. Clin Case Rep. 2022. PMID: 35228880 Free PMC article.
A possible association between Bell's palsy and COVID-19 vaccination has been suggested previously. Here, we report two cases of facial nerve hemiparalysis following the Sputnik V COVID-19 vaccination in a 27-year-old female patien …
A possible association between Bell's palsy and COVID-19 vaccination has been suggested previously. Here, we report two …
Sputnik V vaccine elicits seroconversion and neutralizing capacity to SARS-CoV-2 after a single dose.
Rossi AH, Ojeda DS, Varese A, Sanchez L, Gonzalez Lopez Ledesma MM, Mazzitelli I, Alvarez Juliá A, Oviedo Rouco S, Pallarés HM, Costa Navarro GS, Rasetto NB, Garcia CI, Wenker SD, Ramis LY, Bialer MG, de Leone MJ, Hernando CE, Sosa S, Bianchimano L, Rios AS, Treffinger Cienfuegos MS, Caramelo JJ, Longueira Y, Laufer N, Alvarez DE, Carradori J, Pedrozza D, Rima A, Echegoyen C, Ercole R, Gelpi P, Marchetti S, Zubieta M, Docena G, Kreplak N, Yanovsky M, Geffner J, Pifano M, Gamarnik AV. Rossi AH, et al. Cell Rep Med. 2021 Aug 17;2(8):100359. doi: 10.1016/j.xcrm.2021.100359. Epub 2021 Jul 9. Cell Rep Med. 2021. PMID: 34308389 Free PMC article.
Massive vaccination offers great promise for halting the global COVID-19 pandemic. ...We evaluate SARS-CoV-2-specific antibody responses after Sputnik V vaccination of healthcare workers in Argentina, measuring IgG anti-spik …
Massive vaccination offers great promise for halting the global COVID-19 pandemic. ...We evaluate SARS-CoV …
Pharmacist-directed Sputnik V (GAM-COVID-VAC) surveillance program: a prospective observational study in Southern India.
Karattuthodi MS, Chandrasekher D, Panakkal LM, C S, Salman M, Megha, E MS, Fasil M, A M M, Reji M. Karattuthodi MS, et al. J Basic Clin Physiol Pharmacol. 2022 Feb 16;34(4):509-517. doi: 10.1515/jbcpp-2021-0345. eCollection 2023 Jul 1. J Basic Clin Physiol Pharmacol. 2022. PMID: 35172420
OBJECTIVES: The study underwent to evaluate the adverse events, the incidence of COVID-19 and the participant's attitude and perception towards the vaccine following Sputnik V administration through an active surveillance program. ...On the other hand, …
OBJECTIVES: The study underwent to evaluate the adverse events, the incidence of COVID-19 and the participant's attitude and p …
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants.
Ikegame S, Siddiquey MNA, Hung CT, Haas G, Brambilla L, Oguntuyo KY, Kowdle S, Chiu HP, Stevens CS, Vilardo AE, Edelstein A, Perandones C, Kamil JP, Lee B. Ikegame S, et al. Nat Commun. 2021 Jul 26;12(1):4598. doi: 10.1038/s41467-021-24909-9. Nat Commun. 2021. PMID: 34312390 Free PMC article.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected at least 180 million people since its identification as the cause of the current COVID-19 pandemic. ...Taken together, our data suggest that control of some emergent SA …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected at least 180 million people since its identif …
The Features of COVID-19's Course and the Efficacy of the Gam-COVID-Vac Vaccine in Patients with Paroxysmal Nocturnal Hemoglobinuria.
Ptushkin V, Arshanskaya E, Vinogradova O, Kudlay D, Nikitin E. Ptushkin V, et al. Hematol Rep. 2023 Sep 1;15(3):503-512. doi: 10.3390/hematolrep15030052. Hematol Rep. 2023. PMID: 37754667 Free PMC article.
Testing for anti-SARS-CoV-2 IgG levels was carried out in patients with PNH in the year after their COVID-19. Tests for anti-SARS-CoV-2 RBD IgG levels were performed on vaccinated patients. ...
Testing for anti-SARS-CoV-2 IgG levels was carried out in patients with PNH in the year after their COVID-19 …
Sputnik-V vaccine-induced panniculitis as a local reactions.
Sahraei Z, Abtahi-Naeini B, Saffaei A. Sahraei Z, et al. Clin Case Rep. 2022 Jun 2;10(6):e05923. doi: 10.1002/ccr3.5923. eCollection 2022 Jun. Clin Case Rep. 2022. PMID: 35662784 Free PMC article.
Here, a case of Sputnik-V vaccine-induced panniculitis was reported. The patient developed erythema, induration, and local tenderness at the injection site after 13 days of the injection. ...
Here, a case of Sputnik-V vaccine-induced panniculitis was reported. The patient developed erythema, induration, and local ten …
Sputnik Light and Sputnik V Vaccination Is Effective at Protecting Medical Personnel from COVID-19 during the Period of Delta Variant Dominance.
Sukhikh GT, Priputnevich TV, Ogarkova DA, Pochtovyi AA, Kustova DD, Zlobin VI, Logunov DY, Gushchin VA, Gintsburg AL. Sukhikh GT, et al. Vaccines (Basel). 2022 Oct 26;10(11):1804. doi: 10.3390/vaccines10111804. Vaccines (Basel). 2022. PMID: 36366311 Free PMC article.
Sputnik V and Sputnik Light were the main vaccines used for the prevention of COVID-19. The vaccines are based on a variant of the S-protein of the SARS-CoV-2 virus, with adenovirus serotypes 5 and 26 as the vector fo …
Sputnik V and Sputnik Light were the main vaccines used for the prevention of COVID-19. The vaccines …
Mild Adverse Events of Sputnik V Vaccine in Russia: Social Media Content Analysis of Telegram via Deep Learning.
Jarynowski A, Semenov A, Kamiński M, Belik V. Jarynowski A, et al. J Med Internet Res. 2021 Nov 29;23(11):e30529. doi: 10.2196/30529. J Med Internet Res. 2021. PMID: 34662291 Free PMC article.
BACKGROUND: There is a limited amount of data on the safety profile of the COVID-19 vector vaccine Gam-COVID-Vac (Sputnik V). Previous infodemiology studies showed that social media discourse could be analyzed to assess the most concerning adver …
BACKGROUND: There is a limited amount of data on the safety profile of the COVID-19 vector vaccine Gam-COVID-Vac …
Guillain-Barre Syndrome and COVID-19 Vaccine: A Report of Nine Patients.
Karimi N, Boostani R, Fatehi F, Panahi A, Asghar Okhovat A, Ziaadini B, Basiri K, Abdi S, Sinaei F, Rezaei M, Shamsaei G, Ansari B, Nafissi S. Karimi N, et al. Basic Clin Neurosci. 2021 Sep-Oct;12(5):703-710. doi: 10.32598/bcn.2021.3565.1. Epub 2021 Sep 1. Basic Clin Neurosci. 2021. PMID: 35173924 Free PMC article.
Several studies reported GBS associated with Coronavirus Disease 2019 (COVID-19) infection. In this study, we described nine GBS patients following the COVID-19 vaccine. ...All patients were discharged with some improvements. CONCLUSION: The lin …
Several studies reported GBS associated with Coronavirus Disease 2019 (COVID-19) infection. In this study, we described nine G …
COVID-19 vaccine effectiveness against hospitalizations in Paraguay, May 2021-April 2022: A test-negative design.
Irala S, Hamid S, Penayo E, Michel F, Couto P, Vazquez C, Ortega MJ, Domínguez C, Battaglia S, Von Horoch M, Montoya R, Sequera G, Nogareda F. Irala S, et al. Vaccine. 2023 Oct 13;41(43):6453-6460. doi: 10.1016/j.vaccine.2023.09.015. Epub 2023 Sep 15. Vaccine. 2023. PMID: 37716830
We aimed to estimate the effectiveness of several COVID-19 vaccines in preventing SARS-CoV-2-associated severe acute respiratory infection (SARI) in Paraguay from May 2021 to April 2022. ...We used multivariable logistic regression adjust …
We aimed to estimate the effectiveness of several COVID-19 vaccines in preventing SARS-CoV-2-assoc …
Bell's Palsy and COVID-19 Vaccines: A Systematic Review and Meta-Analysis.
Albakri K, Khaity A, Atwan H, Saleh O, Al-Hajali M, Cadri S, Diab RA, Albazee E, Negida A. Albakri K, et al. Vaccines (Basel). 2023 Jan 20;11(2):236. doi: 10.3390/vaccines11020236. Vaccines (Basel). 2023. PMID: 36851114 Free PMC article. Review.
In this systematic review, we presented evidence about the occurrence of Bell's palsy followed by COVID-19 vaccination. METHODS: We searched PubMed, SCOPUS, EBSCO, and Web of Science (WOS) from inception till October 2022. ...CONCLUSION: The rate ratio of Bel …
In this systematic review, we presented evidence about the occurrence of Bell's palsy followed by COVID-19 vaccination. …
Do Sputnik V Vaccine-Induced Antibodies Protect Against Seasonal Coronaviruses? Case Study.
Koryukov M, Kechin A, Shamovskaya D, Timofeeva A, Filipenko M. Koryukov M, et al. Viral Immunol. 2022 Mar;35(2):138-141. doi: 10.1089/vim.2021.0157. Epub 2022 Feb 10. Viral Immunol. 2022. PMID: 35143357
We established the upper respiratory infection etiology for three patients who had been vaccinated with Sputnik V and tested positive on anti-SARS-CoV-2 antibodies. The symptoms included sore throat, nasal congestion, and myalgia. Their blood se …
We established the upper respiratory infection etiology for three patients who had been vaccinated with Sputnik V and tested p …
COVID-19 vaccines reduce mortality in hospitalized patients with oxygen requirements: Differences between vaccine subtypes. A multicontinental cohort study.
Huespe IA, Ferraris A, Lalueza A, Valdez PR, Peroni ML, Cayetti LA, Mirofsky MA, Boietti B, Gómez-Huelgas R, Casas-Rojo JM, Antón-Santos JM, Núñez-Cortés JM, Lumbreras C, Ramos-Rincón JM, Barrio NG, Pedrera-Jiménez M, Martin-Escalante MD, Ruiz FR, Onieva-García MÁ, Toso CR, Risk MR, Klén R, Pollán JA, Gómez-Varela D. Huespe IA, et al. J Med Virol. 2023 May;95(5):e28786. doi: 10.1002/jmv.28786. J Med Virol. 2023. PMID: 37212340
The aim of this study was to analyze whether the coronavirus disease 2019 (COVID-19) vaccine reduces mortality in patients with moderate or severe COVID-19 disease requiring oxygen therapy. ...Between January 2020 and May 2022, we evaluated 21,4 …
The aim of this study was to analyze whether the coronavirus disease 2019 (COVID-19) vaccine reduces mortality in patie …
Understanding hesitancy with revealed preferences across COVID-19 vaccine types.
Kutasi K, Koltai J, Szabó-Morvai Á, Röst G, Karsai M, Biró P, Lengyel B. Kutasi K, et al. Sci Rep. 2022 Aug 2;12(1):13293. doi: 10.1038/s41598-022-15633-5. Sci Rep. 2022. PMID: 35918372 Free PMC article.
Many countries have secured larger quantities of COVID-19 vaccines than their population is willing to take. The abundance and the large variety of vaccines created not only an unprecedented intensity of vaccine related public discourse, but als …
Many countries have secured larger quantities of COVID-19 vaccines than their population is willing to take. The abunda …
A Comprehensive Review on Various Aspects of SARS-CoV-2 (COVID-19) Vaccines.
Pordanjani SR, Pordanjani AR, Askarpour H, Arjmand M, Babakhanian M, Amiri M, Mazaheri E. Pordanjani SR, et al. Int J Prev Med. 2022 Nov 28;13:151. doi: 10.4103/ijpvm.ijpvm_513_21. eCollection 2022. Int J Prev Med. 2022. PMID: 36911005 Free PMC article. Review.
This is a comprehensive review based on the published papers in the field of COVID-19 vaccines and vaccination. Many efforts have been made to develop vaccines to combat this pandemic. ...At present, protein-based vaccines, with 35% of al …
This is a comprehensive review based on the published papers in the field of COVID-19 vaccines and vaccination. …
Heterologous prime boost COVID 19 vaccination.
Launay O, Thill P. Launay O, et al. Infect Dis Now. 2022 Nov;52(8S):S7-S8. doi: 10.1016/j.idnow.2022.09.011. Epub 2022 Sep 13. Infect Dis Now. 2022. PMID: 36108969 Free PMC article.
Heterologous prime boost vaccination is a primary vaccination with different vaccines, most often from different vaccine platforms. ...For Covid prevention, it has been used in primary vaccination, due to safety issues and in boosters. .. …
Heterologous prime boost vaccination is a primary vaccination with different vaccines, most often from different vac …
Adverse effects following COVID-19 vaccination in Iran.
Babaee E, Amirkafi A, Tehrani-Banihashemi A, SoleimanvandiAzar N, Eshrati B, Rampisheh Z, Asadi-Aliabadi M, Nojomi M. Babaee E, et al. BMC Infect Dis. 2022 May 18;22(1):476. doi: 10.1186/s12879-022-07411-5. BMC Infect Dis. 2022. PMID: 35585518 Free PMC article.
BACKGROUND: Vaccination is a key intervention to prevent COVID-19. Many vaccines are administered globally, yet there is not much evidence regarding their safety and adverse effects. ...COVID-19 vaccines used in Iran are safe and t …
BACKGROUND: Vaccination is a key intervention to prevent COVID-19. Many vaccines are administered globally, yet …
Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview.
Shiravi AA, Ardekani A, Sheikhbahaei E, Heshmat-Ghahdarijani K. Shiravi AA, et al. Cardiol Ther. 2022 Mar;11(1):13-21. doi: 10.1007/s40119-021-00248-0. Epub 2021 Nov 29. Cardiol Ther. 2022. PMID: 34845662 Free PMC article. Review.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the deadly disease known as coronavirus disease 2019 (COVID-19) that has reached pandemic proportions. ...All of these vaccines encode production of the SARS …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the deadly disease known as coronavirus di …
COVID-19 Vaccination Responses with Different Vaccine Platforms in Patients with Inborn Errors of Immunity.
Erra L, Uriarte I, Colado A, Paolini MV, Seminario G, Fernández JB, Tau L, Bernatowiez J, Moreira I, Vishnopolska S, Rumbo M, Cassarino C, Vijoditz G, López AL, Curciarello R, Rodríguez D, Rizzo G, Ferreyra M, Ferreyra Mufarregue LR, Badano MN, Pérez Millán MI, Quiroga MF, Baré P, Ibañez I, Pozner R, Borge M, Docena G, Bezrodnik L, Almejun MB. Erra L, et al. J Clin Immunol. 2023 Feb;43(2):271-285. doi: 10.1007/s10875-022-01382-7. Epub 2022 Oct 17. J Clin Immunol. 2023. PMID: 36251205 Free PMC article.
No difference in humoral response was observed between vaccinated patients with and without previous SARS-CoV-2 infection.In conclusion, COVID-19 vaccines showed safety in IEI patients and, although immunogenicity was lower than HC …
No difference in humoral response was observed between vaccinated patients with and without previous SARS-CoV-2 …
Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study.
Tukhvatulin AI, Dolzhikova IV, Dzharullaeva AS, Grousova DM, Kovyrshina AV, Zubkova OV, Zorkov ID, Iliukhina AA, Shelkov AY, Erokhova AS, Popova O, Ozharovskaia TA, Zrelkin DI, Izhaeva FM, Shcheblyakov DV, Esmagambetov IB, Tokarskaya EA, Nikitenko NA, Lubenets NL, Khadorich EA, Gushchin VA, Borzakova SN, Vlasova AV, Osmanov IM, Gorev VV, Naroditsky BS, Logunov DY, Gintsburg AL. Tukhvatulin AI, et al. Front Immunol. 2023 Aug 1;14:1228461. doi: 10.3389/fimmu.2023.1228461. eCollection 2023. Front Immunol. 2023. PMID: 37600800 Free PMC article. Clinical Trial.
To protect young individuals against SARS-CoV-2 infection, we conducted an open-label, prospective, non-randomised dose-escalation Phase 1/2 clinical trial to evaluate the immunogenicity and safety of the prime-boost "Sputnik V" vaccine administ …
To protect young individuals against SARS-CoV-2 infection, we conducted an open-label, prospective, non-randomised dose …
Insights into COVID-19 vaccines development: Translation from benchside to bedside.
Houssein M, Al Hossainy AEA, Al Soussi J, El Batch J, El-Samadi L, El Imam S, Fakih R, Dakdouk H, Khalil M. Houssein M, et al. Health Sci Rev (Oxf). 2022 Sep;4:100040. doi: 10.1016/j.hsr.2022.100040. Epub 2022 Jul 10. Health Sci Rev (Oxf). 2022. PMID: 35856085 Free PMC article. Review.
Over the past decades, the rapid pace of vaccine development saved 37 million lives, mostly children. The ongoing corona virus disease (COVID-19) pandemic caused the death of more than 4 million worldwide. ...This review was written to the aim of providing a …
Over the past decades, the rapid pace of vaccine development saved 37 million lives, mostly children. The ongoing corona virus diseas …
Acute disseminated encephalomyelitis following the COVID-19 vaccine Ad26.COV2.S, a case report.
Gustavsen S, Nordling MM, Weglewski A. Gustavsen S, et al. Bull Natl Res Cent. 2023;47(1):5. doi: 10.1186/s42269-023-00981-7. Epub 2023 Jan 9. Bull Natl Res Cent. 2023. PMID: 36643729 Free PMC article.
It was necessary to introduce worldwide vaccination program against SARS-CoV-2 virus. Vaccination of billions of people around the world leads to many questions about risk of vaccines and possible side effects. ...CONCLUSIONS: This is, to …
It was necessary to introduce worldwide vaccination program against SARS-CoV-2 virus. Vaccination of bill …
One year update on the COVID-19 pandemic: Where are we now?
Mishra SK, Tripathi T. Mishra SK, et al. Acta Trop. 2021 Feb;214:105778. doi: 10.1016/j.actatropica.2020.105778. Epub 2020 Nov 28. Acta Trop. 2021. PMID: 33253656 Free PMC article. Review.
We are living through an unprecedented crisis with the rapid spread of the new coronavirus disease (COVID-19) worldwide within a short time. The timely availability of thousands of SARS-CoV-2 genomes has enabled the scientific community to study …
We are living through an unprecedented crisis with the rapid spread of the new coronavirus disease (COVID-19) worldwide within …
Heterologous gam-COVID-vac (sputnik V)/mRNA-1273 (moderna) vaccination induces a stronger humoral response than homologous sputnik V in a real-world data analysis.
Pereson MJ, Amaya L, Neukam K, Baré P, Echegoyen N, Badano MN, Lucero A, Martelli A, Garcia GH, Videla C, Martínez AP, Di Lello FA. Pereson MJ, et al. Clin Microbiol Infect. 2022 Oct;28(10):1382-1388. doi: 10.1016/j.cmi.2022.05.009. Epub 2022 May 17. Clin Microbiol Infect. 2022. PMID: 35595128 Free PMC article.
OBJECTIVES: To compare the homologous prime-boost vaccination scheme of Gam-COVID-Vac (Sputnik V (SpV)) to its heterologous combination with mRNA-1273 (Moderna (Mod)) vaccine. METHODS: SARS-CoV-2 anti-spike (S)-receptor binding dom …
OBJECTIVES: To compare the homologous prime-boost vaccination scheme of Gam-COVID-Vac (Sputnik V (SpV)) to its heterolo …
Evaluation of the Gam-COVID-Vac and vaccine-induced neutralizing response against SARS-CoV-2 lineage P.1 variant in an Argentinean cohort.
Blanco S, Salomé Konigheim B, Diaz A, Spinsanti L, Javier Aguilar J, Elisa Rivarola M, Beranek M, Collino C, MinSalCba Working Group, Fcm-Unc Working Group, Diaz M, Gabriela Barbás M, Mangeaud A, Verónica Gallego S. Blanco S, et al. Vaccine. 2022 Jan 31;40(5):811-818. doi: 10.1016/j.vaccine.2021.12.027. Epub 2021 Dec 20. Vaccine. 2022. PMID: 34953609 Free PMC article.
The safety and disease rates among vaccinated individuals were also evaluated. Since SARS-CoV-2 lineage P.1 is rapidly spreading in Argentina, virus-neutralizing activity of Sputnik-V-elicited and infection-elicited NAb faced to P.1 were also as …
The safety and disease rates among vaccinated individuals were also evaluated. Since SARS-CoV-2 lineage P.1 is r …
Review of COVID-19 viral vector-based vaccines and COVID-19 variants.
Vanaparthy R, Mohan G, Vasireddy D, Atluri P. Vanaparthy R, et al. Infez Med. 2021 Sep 10;29(3):328-338. doi: 10.53854/liim-2903-3. eCollection 2021. Infez Med. 2021. PMID: 35146337 Free PMC article. Review.
Efficacy against COVID-19 variants has been found in all but the Convidecia vaccine so far. Heterologous prime-boost COVID-19 vaccination regimen may be the new face and more efficient immunization approach for enhanced immunity against …
Efficacy against COVID-19 variants has been found in all but the Convidecia vaccine so far. Heterologous prime-boost …
Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac).
Jeewandara C, Fernando S, Pushpakumara PD, Ramu ST, Kamaladasa A, Gunasekara B, Aberathna IS, Kuruppu H, Ranasinghe T, Dayarathne S, Dissanayake O, Gamalath N, Ekanayake D, Jayamali J, Wijesinghe A, Dissanayake M, Somathilake G, Harvie M, Danasekara S, Jayathilaka D, Wijayatilake HDK, Weerasooriya N, Kekulandara C, Schimanski L, Rijal P, Tan TK, Dong T, Townsend A, Ogg GS, Malavige GN. Jeewandara C, et al. Sci Rep. 2022 Feb 2;12(1):1727. doi: 10.1038/s41598-022-05788-6. Sci Rep. 2022. PMID: 35110645 Free PMC article.
As the first dose of Gam-COVID-Vac, is currently used as a single dose vaccine in some countries, we investigated the immunogenicity of this at 4 weeks (327 naive individuals). 88.7% seroconverted, with significantly lower seroconversion rates in those over 60 years …
As the first dose of Gam-COVID-Vac, is currently used as a single dose vaccine in some countries, we investigated the immunoge …
Boosting of the SARS-CoV-2-Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine.
Komissarov AA, Dolzhikova IV, Efimov GA, Logunov DY, Mityaeva O, Molodtsov IA, Naigovzina NB, Peshkova IO, Shcheblyakov DV, Volchkov P, Gintsburg AL, Vasilieva E. Komissarov AA, et al. J Immunol. 2022 Mar 1;208(5):1139-1145. doi: 10.4049/jimmunol.2101052. Epub 2022 Jan 31. J Immunol. 2022. PMID: 35101893 Free PMC article.
Although this option is obvious in the case of COVID-19-naive individuals, it is still unclear when individuals who have recovered from a previous SARS-CoV-2 infection should be vaccinated and whether the vaccination raises immune …
Although this option is obvious in the case of COVID-19-naive individuals, it is still unclear when individuals who have recov …
SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines.
Rogliani P, Chetta A, Cazzola M, Calzetta L. Rogliani P, et al. Vaccines (Basel). 2021 Mar 5;9(3):227. doi: 10.3390/vaccines9030227. Vaccines (Basel). 2021. PMID: 33807818 Free PMC article. Review.
Background: There are no studies providing head-to-head comparison across SARS-CoV-2 vaccines. Therefore, we compared the efficacy of candidate vaccines in inducing neutralizing antibodies against SARS-CoV-2. ...Compared wit …
Background: There are no studies providing head-to-head comparison across SARS-CoV-2 vaccines. Therefore, we com …
Impact of vaccination against the novel coronavirus infection (COVID-19) with Sputnik V on mortality during the delta variant surge.
Dmitrieva K, Maslennikov R, Vasilieva E, Aliev S, Bakhitov V, Marcinkevich V, Levshina A, Kozlov E, Ivashkin V, Poluektova E. Dmitrieva K, et al. J Infect Public Health. 2023 Jun;16(6):922-927. doi: 10.1016/j.jiph.2023.04.008. Epub 2023 Apr 13. J Infect Public Health. 2023. PMID: 37086551 Free PMC article.
OBJECTIVES: The aim is to study impact of vaccination against the novel coronavirus disease (COVID-19) with Sputnik V on mortality during the period of predominance of the delta variant of SARS-CoV-2. ...CONCLUSION: COVID- …
OBJECTIVES: The aim is to study impact of vaccination against the novel coronavirus disease (COVID-19) with Sputnik …
Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.
Lim HX, Arip M, Yahaya AAA, Jazayeri SD, Poppema S, Poh CL. Lim HX, et al. Front Biosci (Landmark Ed). 2021 Nov 30;26(11):1286-1304. doi: 10.52586/5024. Front Biosci (Landmark Ed). 2021. PMID: 34856768 Free article. Review.
Three COVID-19 vaccines (BNT162b2, mRNA-1273 and Sputnik V) in clinical Phase III trials have now achieved >90% efficacy in preventing COVID-19. Since SARS-CoV-2 is highly contagious, vaccines are expected t …
Three COVID-19 vaccines (BNT162b2, mRNA-1273 and Sputnik V) in clinical Phase III trials have now achieved >9 …
An unusual occurrence of autoimmune pancreatitis after gam-Covid-Vac (Sputnik V): A case report and literature review.
Chahed F, Ben Fadhel N, Maamri K, Abdelali M, Ben Romdhane H, Chadli Z, Ben Fredj N, Zrig A, Aouam K, Chaabane A. Chahed F, et al. Br J Clin Pharmacol. 2023 Sep;89(9):2915-2919. doi: 10.1111/bcp.15817. Epub 2023 Jul 1. Br J Clin Pharmacol. 2023. PMID: 37311707 Review.
The safety profile of the Sputnik V vaccine is generally reassuring. Nevertheless, an enhanced risk of new-onset of immune-mediated diseases has been increasingly reported following the adenoviral-based Covid-19 vaccine, including inflammatory a …
The safety profile of the Sputnik V vaccine is generally reassuring. Nevertheless, an enhanced risk of new-onset of immune-med …
Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern.
Rudi E, Martin Aispuro P, Zurita E, Gonzalez Lopez Ledesma MM, Bottero D, Malito J, Gabrielli M, Gaillard E, Stuible M, Durocher Y, Gamarnik AV, Wigdorovitz A, Hozbor D. Rudi E, et al. Front Immunol. 2022 Sep 29;13:1020159. doi: 10.3389/fimmu.2022.1020159. eCollection 2022. Front Immunol. 2022. PMID: 36248791 Free PMC article.
The emergency of new SARS-CoV-2 variants that feature increased immune escape marks an urgent demand for better vaccines that will provide broader immunogenicity. ...Used as a booster dose for schedules performed with different authorized vaccines …
The emergency of new SARS-CoV-2 variants that feature increased immune escape marks an urgent demand for better vacc …
Global interest in vaccines during the COVID-19 pandemic: Evidence from Google Trends.
Khakimova A, Abdollahi L, Zolotarev O, Rahim F. Khakimova A, et al. Vaccine X. 2022 Apr;10:100152. doi: 10.1016/j.jvacx.2022.100152. Epub 2022 Mar 11. Vaccine X. 2022. PMID: 35291263 Free PMC article.
COVID-19 (coronavirus disease 2019) vaccines have become available; now, everyone has the opportunity to get vaccinated. ...Interest in user queries was tracked by keywords (corona vaccine, COVID-19 vaccine development, S …
COVID-19 (coronavirus disease 2019) vaccines have become available; now, everyone has the opportunity to get vaccina …
A Systematic Review of the COVID Vaccine's Impact on the Nervous System.
Yella VT, Pareek S, Meena B, Sasanka KSBSK, Thangaraju P, T Y SS. Yella VT, et al. Curr Drug Saf. 2024 Jan 24. doi: 10.2174/0115748863273931231121072231. Online ahead of print. Curr Drug Saf. 2024. PMID: 38275049
For Google Scholar, PubMed, and NCBI databases we used the following key search terms: "neurological adverse effects", "COVID-19 vaccination", "SARS-CoV-2", CNS complications, and CNS adverse effects. ...CONCLUSION: We found no safety sig …
For Google Scholar, PubMed, and NCBI databases we used the following key search terms: "neurological adverse effects", "COVID-19 …
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants.
Ikegame S, Siddiquey MNA, Hung CT, Haas G, Brambilla L, Oguntuyo KY, Kowdle S, Vilardo AE, Edelstein A, Perandones C, Kamil JP, Lee B. Ikegame S, et al. Res Sq [Preprint]. 2021 Apr 8:rs.3.rs-400230. doi: 10.21203/rs.3.rs-400230/v1. Res Sq. 2021. PMID: 33851150 Free PMC article. Updated. Preprint.
Despite the unprecedented pace of vaccine development, with six vaccines already in use worldwide, the emergence of SARS-CoV-2 'variants of concern' (VOC) across diverse geographic locales have prompted re-evaluation of strategies to achieve uni …
Despite the unprecedented pace of vaccine development, with six vaccines already in use worldwide, the emergence of SARS …
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants.
Ikegame S, Siddiquey MNA, Hung CT, Haas G, Brambilla L, Oguntuyo KY, Kowdle S, Vilardo AE, Edelstein A, Perandones C, Kamil JP, Lee B. Ikegame S, et al. medRxiv [Preprint]. 2021 May 29:2021.03.31.21254660. doi: 10.1101/2021.03.31.21254660. medRxiv. 2021. PMID: 33821288 Free PMC article. Updated. Preprint.
Despite the unprecedented pace of vaccine development, with six vaccines already in use worldwide, the emergence of SARS-CoV-2 'variants of concern' (VOC) across diverse geographic locales suggests herd immunity may fail to eliminate the virus. …
Despite the unprecedented pace of vaccine development, with six vaccines already in use worldwide, the emergence of SARS …
Assessment of the humoral response to the homologous Gam-COVID-Vac (Sputnik V) or heterologous Sputnik V/mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in dialysis patients.
Laham G, Martínez AP, Rojas Gimenez W, Amaya L, Abib A, Echegoyen N, Díaz C, Lucero A, Martelli A, Videla C, Neukam K, Di Lello FA. Laham G, et al. J Nephrol. 2023 Apr;36(3):861-872. doi: 10.1007/s40620-022-01446-2. Epub 2022 Sep 24. J Nephrol. 2023. PMID: 36152219 Free PMC article.
BACKGROUND AND AIM: Dialysis patients are a high-risk population and have a reduced immune response to vaccination against SARS-CoV-2. The aim of this study was to assess the humoral response to homologous Gam-COVID-Vac (Sputnik V) and he …
BACKGROUND AND AIM: Dialysis patients are a high-risk population and have a reduced immune response to vaccination against SARS …
Headache following vaccination against COVID-19 among healthcare workers with a history of COVID-19 infection: a cross-sectional study in Iran with a meta-analytic review of the literature.
Nasergivehchi S, Togha M, Jafari E, Sheikhvatan M, Shahamati D. Nasergivehchi S, et al. Head Face Med. 2023 May 19;19(1):19. doi: 10.1186/s13005-023-00363-4. Head Face Med. 2023. PMID: 37202794 Free PMC article. Review.
METHODS: We evaluated the incidence of headaches after injection of different types of COVID-19 vaccine to determine factors relating to the incidence of headache after vaccination among the Iranian healthcare workers who had previously contracted C …
METHODS: We evaluated the incidence of headaches after injection of different types of COVID-19 vaccine to determine fa …
Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study.
Yegorov S, Kadyrova I, Negmetzhanov B, Kolesnikova Y, Kolesnichenko S, Korshukov I, Baiken Y, Matkarimov B, Miller MS, Hortelano GH, Babenko D. Yegorov S, et al. Sci Rep. 2022 Aug 1;12(1):13207. doi: 10.1038/s41598-022-17514-3. Sci Rep. 2022. PMID: 35915123 Free PMC article.
Sputnik-V (Gam-COVID-Vac) is a heterologous, recombinant adenoviral (rAdv) vector-based, COVID-19 vaccine now used in > 70 countries. ...While Sputnik-V reactogenicity is similar to that of other COVID-19 vaccines, …
Sputnik-V (Gam-COVID-Vac) is a heterologous, recombinant adenoviral (rAdv) vector-based, COVID-19 vaccine …
Thrombotic events following Covid-19 vaccines compared to Influenza vaccines.
Vallone MG, Falcón AL, Castro HM, Ferraris A, Cantarella RF, Staneloni MI, Aliperti VI, Ferloni A, Mezzarobba D, Vázquez FJ, Ratti MFG. Vallone MG, et al. Eur J Intern Med. 2022 May;99:82-88. doi: 10.1016/j.ejim.2022.03.002. Epub 2022 Mar 9. Eur J Intern Med. 2022. PMID: 35288031 Free PMC article.
IMPORTANCE: The actual risk of thrombotic events after Covid-19 vaccination is unknown. OBJECTIVE: To evaluate the risk of thrombotic events after Covid-19 vaccination. ...SETTING: Hospital Italiano de Buenos Aires, a tertiary hospital in …
IMPORTANCE: The actual risk of thrombotic events after Covid-19 vaccination is unknown. OBJECTIVE: To evaluate the risk …
Are some COVID-19 vaccines better than others regarding the short-term side effects?
Al-Zidan R, Darweesh O, Salah M, Bebane P, Ahmed H, Abdulrazzaq G, Shanshal S, Alomari N. Al-Zidan R, et al. Ceska Slov Farm. 2023 Winter;72(1):45-54. Ceska Slov Farm. 2023. PMID: 36858979 English.
Controlling the pandemic is primarily achieved through vaccination against COVID-19. Although various COVID-19 vaccines are used worldwide, little is known about their safety and side effects. ...Regarding the post-vaccination side …
Controlling the pandemic is primarily achieved through vaccination against COVID-19. Although various COVID-1 …
The Fast Approval and Slow Rollout of Sputnik V: Why Is Russia's Vaccine Rollout Slower than That of Other Nations?
Mikule E, Reissaar T, Villers J, Takoupo Penka AS, Temerev A, Rozanova L. Mikule E, et al. Epidemiologia (Basel). 2021 Aug 17;2(3):360-376. doi: 10.3390/epidemiologia2030027. Epidemiologia (Basel). 2021. PMID: 36417231 Free PMC article.
The emergence of the SARS-CoV-2 pandemic in the beginning of 2020 led to the deployment of enormous amounts of resources by different countries for vaccine development, and the Russian Federation was the first country in the world to approve a COVID …
The emergence of the SARS-CoV-2 pandemic in the beginning of 2020 led to the deployment of enormous amounts of resource …
Safety and preliminary efficacy of the Gam-COVID-Vac vaccine and outcomes of SARS-CoV-2 infection in Russian patients with genitourinary malignancies.
Tsimafeyeu I, Volkova M, Alekseeva G, Berkut M, Nosov A, Myslevtsev I, Andrianov A, Semenov A, Borisov P, Zukov R, Goutnik V, Savchuk S, Dengina N, Mitin T. Tsimafeyeu I, et al. J Hematol Oncol. 2021 Nov 13;14(1):192. doi: 10.1186/s13045-021-01205-z. J Hematol Oncol. 2021. PMID: 34774086 Free PMC article. Clinical Trial.
BACKGROUND: To our knowledge, there is no clinical data pertaining to COVID-19 outcomes and safety of COVID-19 vaccination in Russian patients with genitourinary (GU) malignancies. ...METHODS: Patients were retrospectively identified at nine can …
BACKGROUND: To our knowledge, there is no clinical data pertaining to COVID-19 outcomes and safety of COVID-19 …
Efficacy and safety of four COVID-19 vaccines in preventing SARS-CoV-2 infection: A rapid review.
Morón-Duarte LS, Chacón KR, Gutiérrez MP, De La Hoz IH, Yomayusa N. Morón-Duarte LS, et al. Biomedica. 2022 Oct 31;42(Sp. 2):19-31. doi: 10.7705/biomedica.6254. Biomedica. 2022. PMID: 36322551 Free PMC article. Review.
INTRODUCTION: Since the emergence of the SARS-CoV-2, there have been efforts to develop vaccines to control the COVID-19 pandemic. ...CONCLUSION: The results of this review support the level of evidence for the efficacy and safety of the …
INTRODUCTION: Since the emergence of the SARS-CoV-2, there have been efforts to develop vaccines to control the …
Understanding the policy dynamics of COVID-19 vaccination in Ghana through the lens of a policy analytical framework.
Atinga RA, Koduah A, Abiiro GA. Atinga RA, et al. Health Res Policy Syst. 2022 Sep 1;20(1):94. doi: 10.1186/s12961-022-00896-1. Health Res Policy Syst. 2022. PMID: 36050739 Free PMC article. Review.
These were complemented by desk reviews of parliamentary reports. RESULTS: The COVID-19 vaccination was mainly framed along the lines of public health, gender-centredness and universal health coverage. ...Regarding issue characteristics of the vaccination …
These were complemented by desk reviews of parliamentary reports. RESULTS: The COVID-19 vaccination was mainly framed a …
Immunoglobulin G antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals may need just one vaccine dose.
Claro F, Silva D, Rodriguez M, Rangel HR, de Waard JH. Claro F, et al. Int J Infect Dis. 2021 Oct;111:261-266. doi: 10.1016/j.ijid.2021.07.070. Epub 2021 Jul 31. Int J Infect Dis. 2021. PMID: 34343704 Free PMC article.
INTRODUCTION: We evaluated the immunoglobulin (Ig) G antibody response against the nucleocapsid protein (NP) and the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 in a cohort of 86 individuals in Venezuela, before and after receiving the …
INTRODUCTION: We evaluated the immunoglobulin (Ig) G antibody response against the nucleocapsid protein (NP) and the receptor-binding domain …
The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland.
Rzymski P, Zeyland J, Poniedziałek B, Małecka I, Wysocki J. Rzymski P, et al. Vaccines (Basel). 2021 Apr 14;9(4):382. doi: 10.3390/vaccines9040382. Vaccines (Basel). 2021. PMID: 33919672 Free PMC article.
Vaccine hesitancy is a major threat to the success of COVID-19 vaccination programs. The present cross-sectional online survey of adult Poles (n = 1020) expressing a willingness to receive the COVID-19 vaccine was conducted between …
Vaccine hesitancy is a major threat to the success of COVID-19 vaccination programs. The present cross-sectional …
Comparative Benefits and Risks Associated with Currently Authorized COVID-19 Vaccines.
Albers JR, Brown JB, Charkowick SV, Ram N, Klocksieben FA, Kumar A. Albers JR, et al. Vaccines (Basel). 2022 Dec 1;10(12):2065. doi: 10.3390/vaccines10122065. Vaccines (Basel). 2022. PMID: 36560476 Free PMC article. Review.
This article provides a systematic assessment of the efficacy, risks, and methodological quality of evidence from five major publicly available vaccine trials. Results from Pfizer-BioNTech mRNA, Moderna-US NIH mRN-1273, AstraZeneca-Oxford ChAdOx1 nCov-19, Gamaleya GamCovid …
This article provides a systematic assessment of the efficacy, risks, and methodological quality of evidence from five major publicly availa …
COVID-19 vaccination and HIV-1 acquisition.
Logunov DY, Livermore DM, Ornelles DA, Bayer W, Marques E, Czerkinsky C, Dolzhikova IV, Ertl HC. Logunov DY, et al. Lancet. 2022 Apr 9;399(10333):e34-e35. doi: 10.1016/S0140-6736(22)00332-4. Lancet. 2022. PMID: 35397866 Free PMC article. No abstract available.
293 results